Several studies have reported that PRR11 overexpression promotes the proliferation, migration, and invasion of ovarian cancer cells by activating the PI3K/AKT/β-Catenin pathway24, and it also can promote the progression of breast cancer by activating EMT39. This evidence concerns the gene PRR11 and breast carcinoma.